{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:12:17Z","timestamp":1789017137120,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1245\/s10434-017-5821-7","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T16:51:40Z","timestamp":1488819100000},"page":"2224-2232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS\/HIPEC"],"prefix":"10.1245","volume":"24","author":[{"given":"Marcel Andr\u00e9","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilmurodjon","family":"Eshmuminov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuno","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"5821_CR1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","volume":"5","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5:219\u201328.","journal-title":"Lancet Oncol."},{"key":"5821_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol."},{"key":"5821_CR3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1403108","volume":"371","author":"F Loupakis","year":"2014","unstructured":"Loupakis F, Cremolini C, Masi G, et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med. 2014;371:1609\u201318.","journal-title":"N Engl J Med."},{"key":"5821_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263\u20137.","journal-title":"J Clin Oncol."},{"key":"5821_CR5","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426\u201332.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR6","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737\u201343.","journal-title":"J Clin Oncol."},{"key":"5821_CR7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol."},{"key":"5821_CR8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00268-015-3366-0","volume":"40","author":"K Lehmann","year":"2016","unstructured":"Lehmann K, Eshmuminov D, Slankamenac K, et al. Where oncologic and surgical complication scoring systems collide: time for a new consensus for CRS\/HIPEC. World J Surg. 2016;40:1075\u201381.","journal-title":"World J Surg."},{"key":"5821_CR9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","volume":"19","author":"BM Ronnett","year":"1995","unstructured":"Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei.\u201d Am J Surg Pathol. 1995;19:1390\u2013408.","journal-title":"Am J Surg Pathol."},{"key":"5821_CR10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1477-7819-12-136","volume":"12","author":"ME Kajdi","year":"2014","unstructured":"Kajdi ME, Beck-Schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol. 2014;12:136.","journal-title":"World J Surg Oncol."},{"key":"5821_CR11","first-page":"610597","volume":"2015","author":"E Halkia","year":"2015","unstructured":"Halkia E, Tsochrinis A, Vassiliadou DT, et al. Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. Int J Surg Oncol. 2015;2015:610597.","journal-title":"Int J Surg Oncol."},{"key":"5821_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","volume":"98","author":"O Glehen","year":"2008","unstructured":"Glehen O, Cotte E, Kusamura S, et al. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol. 2008;98:242\u20136.","journal-title":"J Surg Oncol."},{"key":"5821_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"5821_CR14","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"AM Kuijpers","year":"2013","unstructured":"Kuijpers AM, Mirck B, Aalbers AG, et al. Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol. 2013;20:4224\u201330.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","volume":"19","author":"KK Turaga","year":"2012","unstructured":"Turaga KK, Pappas SG, Gamblin TC. Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol. 2012;19:1379\u201385.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR16","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.10589","volume":"94","author":"ME McCusker","year":"2002","unstructured":"McCusker ME, Cot\u00e9 TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end results program, 1973\u20131998. Cancer. 2002;94:3307\u201312.","journal-title":"Cancer."},{"key":"5821_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.23784","volume":"111","author":"TR Oudheusden van","year":"2015","unstructured":"van Oudheusden TR, Braam HJ, Nienhuijs SW, et al. Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology. J Surg Oncol. 2015;111:237\u201342.","journal-title":"J Surg Oncol."},{"key":"5821_CR18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","volume":"241","author":"TJ Miner","year":"2005","unstructured":"Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241:300\u20138.","journal-title":"Ann Surg."},{"key":"5821_CR19","doi-asserted-by":"crossref","unstructured":"Bruin SC, Verwaal VJ, Vincent A, van\u2019t Veer LJ, van Velthuysen MLF. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol. 2010;17:2330\u201340.","DOI":"10.1245\/s10434-010-0984-5"},{"key":"5821_CR20","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","volume":"22","author":"JM Baumgartner","year":"2015","unstructured":"Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22:1716\u201321.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR21","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","volume":"116","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from non-ovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer. 2010;116:5608\u201318.","journal-title":"Cancer."},{"key":"5821_CR22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jso.23597","volume":"109","author":"HJ Braam","year":"2014","unstructured":"Braam HJ, van Oudheusden TR, de Hingh IHJT, et al. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. J Surg Oncol. 2014;109:841\u20137.","journal-title":"J Surg Oncol."},{"key":"5821_CR23","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier A-S, et al. Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol. 2014;40:1467\u201373.","journal-title":"Eur J Surg Oncol."},{"key":"5821_CR24","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Go\u00e9r\u00e9","year":"2015","unstructured":"Go\u00e9r\u00e9 D, Souadka A, Faron M, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22:2958\u201364.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/SLA.0b013e3181b5ae43","volume":"251","author":"TC Chua","year":"2010","unstructured":"Chua TC, Saxena A, Schellekens JF, et al. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg. 2010;251:101\u20136.","journal-title":"Ann Surg."},{"issue":"13","key":"5821_CR26","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1245\/s10434-016-5355-4","volume":"23","author":"C Ihemelandu","year":"2016","unstructured":"Ihemelandu C, Mavros MN, Sugarbaker P, Adverse events postoperatively had no impact on long-term survival of patients treated with cytoreductive surgery with heated intraperitoneal chemotherapy for appendiceal cancer with peritoneal metastases. Ann Surg Oncol. 2016;23(13):4231\u20137.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR27","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22:2656\u201362.","journal-title":"Ann Surg Oncol."},{"key":"5821_CR28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ejso.2016.03.004","volume":"42","author":"F Wallet","year":"2016","unstructured":"Wallet F, Maucort Boulch D, Malfroy S, et al. No impact on long-term survival of prolonged ICU stay and re-admission for patients undergoing cytoreductive surgery with HIPEC. Eur J Surg Oncol. 2016;42:855\u201360.","journal-title":"Eur J Surg Oncol."},{"key":"5821_CR29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ejso.2013.10.015","volume":"40","author":"M Valle","year":"2014","unstructured":"Valle M, Federici O, Carboni F, et al. Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis: proposal and results from a prospective protocol study of prevention, surveillance and treatment. Eur J Surg Oncol. 2014;40:950\u20136.","journal-title":"Eur J Surg Oncol."},{"key":"5821_CR30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jso.20837","volume":"96","author":"A Capone","year":"2007","unstructured":"Capone A, Valle M, Proietti F, Federici O, Garofalo A, Petrosillo N. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis. J Surg Oncol. 2007;96:507\u201313.","journal-title":"J Surg Oncol."},{"key":"5821_CR31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249:900\u20137.","journal-title":"Ann Surg."},{"key":"5821_CR32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5114\/ceji.2015.52835","volume":"40","author":"AM Binkowska","year":"2015","unstructured":"Binkowska AM, Michalak G, S\u0142otwi\u0144ski R. Current views on the mechanisms of immune responses to trauma and infection. Cent Eur J Immunol. 2015;40:206\u201316.","journal-title":"Cent Eur J Immunol."},{"key":"5821_CR33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374.","journal-title":"Nat Rev Immunol."},{"key":"5821_CR34","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jss.2012.01.015","volume":"179","author":"K Votanopoulos","year":"2013","unstructured":"Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA. A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. J Surg Res. 2013;179:e133\u20139.","journal-title":"J Surg Res."},{"key":"5821_CR35","first-page":"70","volume":"2","author":"RD Becher","year":"2011","unstructured":"Becher RD, Shen P, Stewart JH, Russell G, Bradley JF, Levine EA. Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol. 2011;2:70\u20136.","journal-title":"J Gastrointest Oncol."},{"key":"5821_CR36","first-page":"61","volume":"2","author":"N Deslauriers","year":"2011","unstructured":"Deslauriers N, Olney H, Younan R. Splenectomy revisited in 2011: impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Gastrointest Oncol. 2011;2:61\u20133.","journal-title":"J Gastrointest Oncol."},{"key":"5821_CR37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.surg.2015.09.013","volume":"159","author":"JT Melero","year":"2016","unstructured":"Melero JT, Ortega FG, Gonzalez AM, et al. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS\u00a0+\u00a0HIPEC). Surgery. 2016;159:728\u201335.","journal-title":"Surgery."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-5821-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5821-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T10:15:25Z","timestamp":1568888125000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-5821-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["5821"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-5821-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]}}}